Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

Nickel Reduces Calcium Dependent Dimerization in Neural Cadherin

The Role of Platelet Function Testing in Improving Clinical Outcomes

Experimental Study on the Hemostatic Effect of Cyanoacrylate Intended for Catheter Securement

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes: the TRACER pharmacodynamic substudy

ST-segment elevation acute coronary syndrome (from the TRACER Trial).

Tetraspanin CD9 Regulates Cell Contraction and Actin Arrangement via RhoA in Human Vascular Smooth Muscle Cells

PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial.

Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion model.

Please reload

CirQuest Labs
140 Collins Street

Memphis, TN 38112

Phone: 901.866.1700

Fax: 901.866.1702

  • White LinkedIn Icon
  • White Twitter Icon

© 2020 CirQuest Labs All Rights Reserved

Website Built and Designed by Savannah Worcester